Gabriel Cabot
Gabriel Cabot
Researcher
Verified email at ssib.es
Title
Cited by
Cited by
Year
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
208*2012
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study
G Cabot, AA Ocampo-Sosa, F Tubau, MD Macia, C Rodríguez, B Moya, ...
Antimicrobial agents and chemotherapy 55 (5), 1906-1911, 2011
1912011
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ...
Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011
1802011
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
1662014
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
1442016
Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections
C Peña, G Cabot, S Gómez-Zorrilla, L Zamorano, A Ocampo-Sosa, ...
Clinical Infectious Diseases 60 (4), 539-548, 2015
1352015
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
1282012
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
1282012
Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study
AA Ocampo-Sosa, G Cabot, C Rodríguez, E Roman, F Tubau, MD Macia, ...
Antimicrobial agents and chemotherapy 56 (4), 1703-1713, 2012
1112012
Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals
M García-Castillo, R Del Campo, MI Morosini, E Riera, G Cabot, ...
Journal of clinical microbiology 49 (8), 2905-2910, 2011
1032011
The versatile mutational resistome of Pseudomonas aeruginosa
C López-Causapé, G Cabot, E del Barrio-Tofiño, A Oliver
Frontiers in microbiology 9, 685, 2018
1012018
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
1012013
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
PA Fraile-Ribot, G Cabot, X Mulet, L Periañez, ML Martín-Pena, C Juan, ...
Journal of Antimicrobial Chemotherapy 73 (3), 658-663, 2018
992018
Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain
E del Barrio-Tofiño, C López-Causapé, G Cabot, A Rivera, N Benito, ...
Antimicrobial agents and chemotherapy 61 (11), e01589-17, 2017
902017
Evolution of the Pseudomonas aeruginosa mutational resistome in an international cystic fibrosis clone
C López-Causapé, LM Sommer, G Cabot, R Rubio, AA Ocampo-Sosa, ...
Scientific reports 7 (1), 1-15, 2017
792017
Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection
C Lopez-Causape, E Rojo-Molinero, X Mulet, G Cabot, B Moya, ...
PLoS One 8 (8), e71001, 2013
772013
Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing
G Cabot, C López-Causapé, AA Ocampo-Sosa, LM Sommer, ...
Antimicrobial agents and chemotherapy 60 (12), 7415-7423, 2016
762016
Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-β-lactamases
C Scotta, C Juan, G Cabot, A Oliver, J Lalucat, A Bennasar, S Albertí
Antimicrobial agents and chemotherapy 55 (11), 5376-5379, 2011
662011
NagZ Inactivation Prevents and Reverts β-Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa
L Zamorano, TM Reeve, L Deng, C Juan, B Moyá, G Cabot, DJ Vocadlo, ...
Antimicrobial agents and chemotherapy 54 (9), 3557-3563, 2010
622010
Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure
A Ropy, G Cabot, I Sánchez-Diener, C Aguilera, B Moya, JA Ayala, ...
Antimicrobial agents and chemotherapy 59 (7), 3925-3934, 2015
582015
The system can't perform the operation now. Try again later.
Articles 1–20